Boston Scientific Corporation - BSX Net earnings per share growth forecast for next year
The forward EPS growth indicator for n+1 demonstrates how cost optimization during the expansion of cardiology production increases operating profit. The current indicator holds at -1.30, confirming market expectations. Boston Scientific (BSX) revenues are based on the sale of micro-implants and high-tech equipment. Business resilience is ensured by the integration of monitoring systems and close cooperation with medical centers.
BSX (bostonscientific.com): analytical breakdowns and indicator data
- stock quotes and analyst forecast:
- issuer market value details:
- company book value details:
- company liabilities and liquidity data:
Total Debt to Capital Boston Scientific|BSX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Boston Scientific Corporation|BSX - Company Total Debt|Debts to Book Capitalization Boston Scientific|BSX - Company Long-Term Debts|Company Short-Term Debt Boston Scientific|Quick Liquidity Indicator bostonscientific.com
- earnings and valuation multiples information:
BSX - Final Profit|Projected Future Earnings Boston Scientific|BSX - Market Cap to Earnings|Future Price to Earnings Boston Scientific|BSX - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Boston Scientific|BSX - Operating profit EBITDA|Net earnings per share (EPS TTM) Boston Scientific|BSX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months bostonscientific.com|BSX - Earnings per share trend in current year|Net earnings per share growth forecast for next year Boston Scientific
Comprehensive company analysis:Boston Scientific Inc, BSX
Identifying assets with a fundamental margin of safety requires an analysis of future cash flows. This indicator measures earnings per share growth rates, reflecting the discounting of the company's prospects relative to the cost of capital. For Boston Scientific (BSX), cash inflows from new cardiac devices offset the risks of expensive loans. The expected EPS growth for the coming year allows for an assessment of this model's resilience to market cycles.
Main competitors
Expected earnings per share growth for next year EW|RMD: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insulet Corporation (PODD)|Expected earnings per share growth for next year Zimmer Biomet Holdings, Inc. ZBH|Earnings growth forecast for next year COO (CooperCompanies)|Invisalign (ALGN) - Expected net earnings per share growth next year|Globus Medical Corp - Earnings growth forecast for next year|TMDX (TransMedics Group) - Projected earnings per share growth rate for next year|ATEC: Earnings growth forecast for next year|AORT - Consensus forecast of earnings per share growth for next year|ENOV (Enovis) - Earnings growth forecast for next year|Expected earnings per share growth for next year Integra LifeSciences Corp (IART)|Earnings growth forecast for next year ESTA|Earnings growth forecast for next year iLet Bionic Pancreas (BBNX)|Net earnings per share growth forecast for next year IRADIMED CORPORATION IRMD|embecta.com - Net earnings per share growth forecast for next year|TNDM: Expected earnings per share growth for next year|Expected earnings per share trend next year AXGN (AxoGen Inc)|SIBN: Earnings growth forecast for next year|Expected net earnings per share growth next year Orthofix Corp (OFIX)|Net earnings per share growth forecast for next year Bioventus Inc.|KIDS - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year TMCI (Treace Medical Concepts, Inc.)|Earnings growth forecast for next year Blade Air Mobility (SRTA)|Earnings growth forecast for next year CARL (Carlsmed Corp)|Consensus forecast of earnings per share growth for next year RxSight Ophthalmic (RXST)|CLPT - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year STXS|Neuronetics (STIM) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Sight Sciences Inc.|OBIO (Orchestra BioMed, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Anika ANIK|Net earnings per share growth forecast for next year InspireMD, Inc. (NSPR)|zhjmedical.com - Projected earnings per share growth rate for next year|Vivani Medical - Expected earnings per share growth for next year|Projected earnings per share increase next year XTNT (Xtant Medical Holdings, Inc.)|NeuroOne Corp - Earnings growth forecast for next year|MODD: Net earnings per share growth forecast for next year|Myomo, Inc. (MYO) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year envoymedical.com (COCH)|Net earnings per share growth forecast for next year Vivos Therapeutics, Inc.|enVVeno Medical Corporation (NVNO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SINT (Sintx Technologies)|Projected earnings per share increase next year TNON|Net earnings per share growth forecast for next year ReWalk Robotics Ltd. LFWD|Autonomix Medical Inc. (AMIX) - Expected net earnings per share growth next year|IVF - Net earnings per share growth forecast for next year|BBLG (Bone Biologics Corp.) - Projected earnings per share growth rate for next year|AXNX (Axonics Modulation Technologies) - Expected earnings per share growth for next year|Biolase Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Dynatronics Corp|Paragon 28 Corp (FNA) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year INVO
